Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparative Study of Nursing Home-Acquired Pneumonia with Community-Acquired Pneumonia

  • Received : 2010.12.21
  • Accepted : 2011.01.20
  • Published : 2011.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Little data is available regarding hospitalized patients with nursing home-acquired pneumonia (NHAP). This is unfortunate because there is an increasing number of elderly persons who are living in nursing homes in Korea. The aim of this study was to compare clinical characteristics and treatment responses of NHAP with community-acquired pneumonia (CAP). Methods: Patients with pneumonia who were admitted from eight nursing homes or from their own homes were enrolled between May 2007 and April 2009. Their clinical characteristics and treatment responses were reviewed retrospectively, and differences between the two groups were analyzed. Results: Of 110 Patients with pneumonia, 66 (60%) were from nursing homes and their median age was 84. In the NHAP group, functional performance status was significantly poorer, classical symptoms of pneumonia were less severe, and multi-lobe involvement (on chest radiographs) was more frequent than in the CAP group. Patients with NHAP more frequently showed lymphocytopenia, anemia, hypoalbuminemia, hypoxemia, and elevated blood urea nitrogen on admission. The mean CURB-65 score was 2.2 in the NHAP group, higher than 1.7 in the CAP group (p=0.004), and multi-drug resistant pathogens were also highly identified in NHAP group (39% vs. 10%, p=0.036). The mean duration of antibiotic therapy was greater for the NHAP (12.6 days) than for the CAP group (6.6 days) (p<0.001). The mortality rate was 23% in NHAP group, which was significantly higher than 5% in the CAP group (p=0.014). Conclusion: NHAP should be more intensively investigated because of the higher frequency of multi-drug resistant pathogens and mortality than the CAP.

Keywords

References

  1. Carratala J, Mykietiuk A, Fernandez-Sabe N, Suarez C, Dorca J, Verdaguer R, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007;167:1393-9. https://doi.org/10.1001/archinte.167.13.1393
  2. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-62. https://doi.org/10.1378/chest.128.6.3854
  3. Division of Senior Policy in the Office of Aging Society and Population Policy. Current status of the long-term care facilities of the elderly. Seoul: Ministry of Health and Welfare, Republic of Korea; 2008.
  4. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416. https://doi.org/10.1164/rccm.200405-644ST
  5. Polverino E, Dambrava P, Cilloniz C, Balasso V, Marcos MA, Esquinas C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010;65:354-9. https://doi.org/10.1136/thx.2009.124776
  6. Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112-24. https://doi.org/10.1016/S1473-3099(04)00931-4
  7. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010;10:279-87. https://doi.org/10.1016/S1473-3099(10)70032-3
  8. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568-73. https://doi.org/10.1128/AAC.00851-07
  9. Carratala J, Fernandez-Sabe N, Ortega L, Castellsague X, Roson B, Dorca J, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 2005;142:165-72. https://doi.org/10.7326/0003-4819-142-3-200502010-00006
  10. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18:362-8. https://doi.org/10.1183/09031936.01.00204401
  11. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55. https://doi.org/10.1097/00000421-198212000-00014
  12. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82. https://doi.org/10.1136/thorax.58.5.377
  13. Yoon WK, Kim M, Kim YY, Lee YJ, Hwangbo Y, Choi KJ, et al. The clinical and microbial characteristics of healthcare-associated pneumonia. Korean J Med 2010;78:709-16.
  14. Committee for the Japanese Respiratory Society Guidelines in Management of Respiratory. Appendix I: nursing-home acquired pneumonia. Respirology 2004;9 Suppl 1:S51-5. https://doi.org/10.1111/j.1440-1843.2003.00564.x
  15. Johnson JC, Jayadevappa R, Baccash PD, Taylor L. Nonspecific presentation of pneumonia in hospitalized older people: age effect or dementia? J Am Geriatr Soc 2000;48:1316-20. https://doi.org/10.1111/j.1532-5415.2000.tb02607.x
  16. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003;124:328-36. https://doi.org/10.1378/chest.124.1.328
  17. Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005;40:1-6. https://doi.org/10.1086/426023
  18. Shanley C, O'Loughlin G. Dysphagia among nursing home residents: an assessment and management protocol. J Gerontol Nurs 2000;26:35-48.
  19. Falcone M, Serra P, Licata G, Venditti M; Italian Society of Internal Medicine (SIMI). Health care associated pneumonia: a new clinical entity. Arch Intern Med 2008;168:109-10.
  20. Mylotte JM. Nursing home-associated pneumonia. Clin Geriatr Med 2007;23:553-65, vi-vii. https://doi.org/10.1016/j.cger.2007.02.003
  21. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002;165:766-72. https://doi.org/10.1164/ajrccm.165.6.2103038
  22. Niederman MS, Brito V. Pneumonia in the older patient. Clin Chest Med 2007;28:751-71, vi. https://doi.org/10.1016/j.ccm.2007.08.004
  23. Loeb M, Carusone SC, Goeree R, Walter SD, Brazil K, Krueger P, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006;295:2503-10. https://doi.org/10.1001/jama.295.21.2503
  24. El Solh AA, Pietrantoni C, Bhat A, Bhora M, Berbary E. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin Infect Dis 2004;39:474-80. https://doi.org/10.1086/422317

Cited by

  1. Pneumonia Observed in a Geriatric Hospital vol.19, pp.2, 2015, https://doi.org/10.4235/jkgs.2015.19.2.80
  2. Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital vol.30, pp.5, 2011, https://doi.org/10.3904/kjim.2015.30.5.638
  3. Facility characteristics as independent prognostic factors of nursing home-acquired pneumonia vol.31, pp.2, 2016, https://doi.org/10.3904/kjim.2014.256
  4. Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia vol.58, pp.1, 2017, https://doi.org/10.3349/ymj.2017.58.1.180
  5. Stagnation of life expectancy in Korea in 2018: A cause-specific decomposition analysis vol.15, pp.12, 2020, https://doi.org/10.1371/journal.pone.0244380